OTR3
Desconocido
SMR: Stroke Management through RGTA SMR
ORGANES TISSUS REGENERATION REPARATION REMPLACEMENT
tramitó un
H2020:
H2020-EIC-SMEInst-2018-2020
Stroke is the 2nd cause of death and major handicaps in industrialized countries. At present, the only available treatment for ischemic stro...
2018-08-08 - 2024-05-31 | Financiado
2018-08-08 - 2024-05-31 | Financiado
CASCADE: Cultivated Adult Stem Cells as Alternative for Damaged tissue
ORGANES TISSUS REGENERATION REPARATION REMPLACEMENT
participó en un
FP7:
Rapid progress in stem cell research pave the way for the development and use of new cell therapy products in regenerative medicine. The obj...
Financiado
Financiado
* No se disponen de datos de la empresa actual.